FIRST AMENDMENT TO THE SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 6th, 2023 • Fennec Pharmaceuticals Inc. • Biological products, (no disgnostic substances)
This FIRST AMENDMENT TO THE SECURITIES PURCHASE AGREEMENT (this “First Amendment”) is dated as of December 4, 2023 and is made in reference to that certain Securities Purchase Agreement, dated as of August 1, 2022 (as may be amended, restated or otherwise modified from time to time, the “Purchase Agreement”), by and among Fennec Pharmaceuticals, Inc., a British Columbia corporation (the “Company”), the investors party thereto (the “Investors”), and Petrichor Opportunities Fund I LP, as collateral agent (collectively, the “Parties”).
